Compare GHM & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHM | CMPS |
|---|---|---|
| Founded | 1936 | 2020 |
| Country | United States | United Kingdom |
| Employees | 732 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1994 | 2020 |
| Metric | GHM | CMPS |
|---|---|---|
| Price | $109.77 | $12.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $73.33 | $25.38 |
| AVG Volume (30 Days) | 271.8K | ★ 3.4M |
| Earning Date | 06-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.90 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $245,293,000.00 | N/A |
| Revenue This Year | $14.54 | N/A |
| Revenue Next Year | $18.23 | N/A |
| P/E Ratio | $96.35 | ★ N/A |
| Revenue Growth | ★ 16.86 | N/A |
| 52 Week Low | $46.08 | $2.47 |
| 52 Week High | $119.04 | $14.76 |
| Indicator | GHM | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 58.03 | 59.47 |
| Support Level | $88.46 | $5.48 |
| Resistance Level | N/A | $14.76 |
| Average True Range (ATR) | 7.43 | 0.90 |
| MACD | 0.57 | -0.08 |
| Stochastic Oscillator | 72.23 | 63.82 |
Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.